Published on:January 2019
Indian Journal of Pharmacy Practice, 2019; 12(1):01
Editorial | doi:10.5530/ijopp.12.1.1


Authors and affiliation (s):

Dr. Shobha Rani. R.H



Dear Readers,

At the outset, on behalf of the entire Editorial team of ijopp, I wish you all a very happy and prosperous New Year 2019.

Over the last three decades, India has become a hub of vaccine manufacturing with state-of-the-art facilities at par with the International manufacturing standards. India is now producing vaccine products which are available in both domestic and international markets. This warrant additional responsibility of vigilance of vaccine products.

National Regulatory Authorities (NRA) are responsible for ensuring that all vaccines, used within the country are of quality, effective and safe. A national immunization programme (NIP) is the organizational component of Ministry of Health responsible for preventing disease, disability, and death from vaccine-preventable diseases in children and adults. Read more...


The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmacy Practice (IJOPP) [ISSN-0974-8326] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 2008.


IJOPP uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2014 are being assigned DOIs for its permanent URLs